Immediate Impact

74 standout
Sub-graph 1 of 23

Citing Papers

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association
2024 Standout
2 intermediate papers

Works of Ying Bai being referenced

Meta-Analysis of Effectiveness and Safety of Oral Anticoagulants in Atrial Fibrillation With Focus on Apixaban
2017
The Global Burden of Atrial Fibrillation and Stroke
2017

Author Peers

Author Last Decade Papers Cites
Ying Bai 456 135 129 30 639
Douglas A. Dulli 201 155 285 23 657
E.L.L.M. De Schryver 207 99 291 20 661
Thomas Toell 163 39 288 23 622
Søren Bak 294 33 200 19 670
Ayeesha Kamran Kamal 193 183 392 49 669
Pratik Bhattacharya 99 55 301 41 657
Mollie McDermott 115 41 225 25 718
Ryo Itabashi 163 85 312 59 561
Marta Sorribes 181 84 118 28 559
Francesca Romana Pezzella 94 40 228 61 586

All Works

Loading papers...

Rankless by CCL
2026